how long do you use semaglutide for weight loss Loss: What to Know Who Qualifies for Semaglutide GLP-1

What's New: July 2026 Update TRIUMPH-4 confirmed: Retatrutide 28.7% weight loss in Phase 3 (December 2025) final data, not preliminary TRIUMPH-1 CONFIRMED (May 21, 2026): 28.3% average weight loss at 80 weeks in 2,339 patients without diabetes pivotal trial met all primary endpoints Availability unchanged: Retatrutide still investigational, no FDA approval until late 2027 at earliest Tirzepatide still the best available option: 22.5% weight loss, FDA-approved, available today TRANSCEND-T2D-1 confirmed (June 2026): -2.0% HbA1c and 16.8% weight loss in type 2 diabetes patients a separate diabetes-specific Phase 3 program NDA timeline on track: industry estimates continue to expect Q4 2026 filing, following TRIUMPH-1's positive readout Introduction The evolution of weight loss medications has progressed rapidly from single-agonist drugs to multi-agonist approaches

Patients experience a safe and effective pathway to achieving their weight management goals

Immediately place it in the refrigerator (for short-term storage) or the freezer (for long-term storage)

Frequently Asked Questions Does semaglutide injection directly cause hair loss

The authors had permission to access and use the data from both the IQVIA LRx databases, and ethical approval was not required for secondary use of these data